Abivax annual net debt
2021
2022
2023
2024
2025
Abivax Net Debt Growth & History (ABVX)
Abivax's net debt was −€514.8M for fiscal 2025.
View full Abivax company overviewAbivax annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −€514.8M | −€373.0M | — |
| 2024 | 2024-12-31 | −€141.9M | €109.5M | — |
| 2023 | 2023-12-31 | −€251.4M | −€225.8M | — |
| 2022 | 2022-12-31 | −€25.6M | €34.9M | — |
| 2021 | 2021-12-31 | −€60.5M | — | — |
Abivax quarterly net debt
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | −€476.0M | −€374.5M | — |
| Q4 2025 | 2025-12-31 | −€514.8M | −€373.0M | — |
| Q3 2025 | 2025-09-30 | −€588.2M | — | — |
| Q2 2025 | 2025-06-30 | −€59.1M | — | — |
| Q1 2025 | 2025-03-31 | −€101.5M | — | — |
| Q4 2024 | 2024-12-31 | −€141.9M | €109.5M | — |
| Q4 2023 | 2023-12-31 | −€251.4M | — | — |
Abivax net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Abivax's net debt decreased from −€60.5M to −€514.8M, a change of −€454.3M. The latest reported quarter, Q1 2026, shows −€476.0M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Abivax source filings ↗